SCHEMBL6026359

SCHEMBL6026359

CCCCCCCCCCCCCCC(c1ccccc1)(c1ccccc1)c1ccccc1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SGMS2 Q8NHU3 1/20 0.42
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
LIPE Q05469 1/20 0.40
CNR1 P21554 3/20 0.39
CNR2 P34972 3/20 0.39
BCHE P06276 2/20 0.39
TLR4 O00206 1/20 0.39
TLR3 O15455 1/20 0.39
TLR5 O60602 1/20 0.39
TLR2 O60603 1/20 0.39
CAMK2B Q13554 1/20 0.39
CAMK2G Q13555 1/20 0.39
CAMK2D Q13557 1/20 0.39
CAMK1 Q14012 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081107 0.81 KIF11 (0.38) MAPTCNR1CNR2CYP2D6KIF11
SCHEMBL1614610 0.79 RXRA (0.43) MAPTMAPK1TDP1L3MBTL1SGMS2
SCHEMBL1614851 0.79 RXRA (0.43) MAPTMAPK1TDP1L3MBTL1SGMS2
SCHEMBL28524935 0.78 CNR1 (0.38) MAPTCNR1CNR2GAAKIF11
SCHEMBL3081113 0.78 CNR1 (0.38) MAPTCNR1CNR2GAAKIF11
SCHEMBL27595906 0.75 KIF11 (0.57) CYP2D6GAAKIF11
SCHEMBL5868580 0.75 KIF11 (0.57) CYP2D6GAAKIF11
SCHEMBL28062215 0.75 KIF11 (0.57) CYP2D6GAAKIF11
SCHEMBL27676286 0.75 KIF11 (0.57) CYP2D6GAAKIF11
SCHEMBL17817860 0.75 KIF11 (0.57) CYP2D6GAAKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1622602-A4 METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID GEN HOSPITAL CORP (US) 2006-06-21 EP disclosed
EP-1622602-A2 METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID THE GENERAL HOSPITAL CORPORATION (US) 2006-02-08 EP disclosed
WO-2004093650-A2 METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID THE GENERAL HOSPITAL CORPORATION (US) 2004-11-04 WO disclosed